位置:首页 > 蛋白库 > KTNA1_CAEEL
KTNA1_CAEEL
ID   KTNA1_CAEEL             Reviewed;         472 AA.
AC   P34808; Q8I4G6;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Meiotic spindle formation protein mei-1 {ECO:0000255|HAMAP-Rule:MF_03023};
DE            EC=5.6.1.1 {ECO:0000255|HAMAP-Rule:MF_03023, ECO:0000269|PubMed:28783150};
DE   AltName: Full=Katanin p60 ATPase-containing subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023};
DE            Short=Katanin p60 subunit A1 {ECO:0000255|HAMAP-Rule:MF_03023};
DE   AltName: Full=p60 katanin {ECO:0000255|HAMAP-Rule:MF_03023};
GN   Name=mei-1 {ECO:0000255|HAMAP-Rule:MF_03023}; ORFNames=T01G9.5;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORMS A AND B),
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF ARG-36; GLU-66; PRO-99; GLY-126;
RP   ARG-128; ILE-195; PRO-225; LEU-231; PRO-235; GLU-308; PRO-360; ARG-414 AND
RP   GLY-470.
RC   STRAIN=Bristol N2;
RX   PubMed=8150281; DOI=10.1093/genetics/136.2.533;
RA   Clark-Maguire S., Mains P.E.;
RT   "mei-1, a gene required for meiotic spindle formation in Caenorhabditis
RT   elegans, is a member of a family of ATPases.";
RL   Genetics 136:533-546(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=8027178; DOI=10.1083/jcb.126.1.199;
RA   Clark-Maguire S., Mains P.E.;
RT   "Localization of the mei-1 gene product of Caenorhaditis elegans, a
RT   meiotic-specific spindle component.";
RL   J. Cell Biol. 126:199-209(1994).
RN   [4]
RP   FUNCTION, INTERACTION WITH MEI-2, AND SUBCELLULAR LOCATION.
RX   PubMed=10809666;
RA   Srayko M., Buster D.W., Bazirgan O.A., McNally F.J., Mains P.E.;
RT   "MEI-1/MEI-2 katanin-like microtubule severing activity is required for
RT   Caenorhabditis elegans meiosis.";
RL   Genes Dev. 14:1072-1084(2000).
RN   [5]
RP   REGULATION BY UBIQUITIN MEDIATED PROTEOLYSIS.
RX   PubMed=11847342; DOI=10.1126/science.1067765;
RA   Kurz T., Pintard L., Willis J.H., Hamill D.R., Goenczy P., Peter M.,
RA   Bowerman B.;
RT   "Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification
RT   pathway.";
RL   Science 295:1294-1298(2002).
RN   [6]
RP   REGULATION BY UBIQUITIN MEDIATED PROTEOLYSIS, AND SUBCELLULAR LOCATION.
RX   PubMed=12781129; DOI=10.1016/s0960-9822(03)00336-1;
RA   Pintard L., Kurz T., Glaser S., Willis J.H., Peter M., Bowerman B.;
RT   "Neddylation and deneddylation of CUL-3 is required to target MEI-1/katanin
RT   for degradation at the meiosis-to-mitosis transition in C. elegans.";
RL   Curr. Biol. 13:911-921(2003).
RN   [7]
RP   FUNCTION.
RX   PubMed=12885567; DOI=10.1016/s0012-1606(03)00216-1;
RA   Yang H.-Y., McNally K., McNally F.J.;
RT   "MEI-1/katanin is required for translocation of the meiosis I spindle to
RT   the oocyte cortex in C elegans.";
RL   Dev. Biol. 260:245-259(2003).
RN   [8]
RP   INTERACTION WITH MEL-26, AND REGULATION BY UBIQUITIN MEDIATED PROTEOLYSIS.
RX   PubMed=13679921; DOI=10.1038/nature01959;
RA   Pintard L., Willis J.H., Willems A., Johnson J.-L.F., Srayko M., Kurz T.,
RA   Glaser S., Mains P.E., Tyers M., Bowerman B., Peter M.;
RT   "The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3
RT   ubiquitin-ligase.";
RL   Nature 425:311-316(2003).
RN   [9]
RP   INTERACTION WITH MEL-26, AND REGULATION BY UBIQUITIN MEDIATED PROTEOLYSIS.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [10]
RP   SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, PHOSPHORYLATION AT SER-92, AND
RP   MUTAGENESIS OF ARG-36 AND SER-92.
RX   PubMed=16338136; DOI=10.1016/j.cub.2005.11.063;
RA   Stitzel M.L., Pellettieri J., Seydoux G.;
RT   "The C. elegans DYRK Kinase MBK-2 marks oocyte proteins for degradation in
RT   response to meiotic maturation.";
RL   Curr. Biol. 16:56-62(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH PPH-4.1, AND MUTAGENESIS OF PRO-99 AND GLU-308.
RX   PubMed=19087961; DOI=10.1534/genetics.108.096016;
RA   Han X., Gomes J.E., Birmingham C.L., Pintard L., Sugimoto A., Mains P.E.;
RT   "The role of protein phosphatase 4 in regulating microtubule severing in
RT   the Caenorhabditis elegans embryo.";
RL   Genetics 181:933-943(2009).
RN   [12]
RP   FUNCTION, INTERACTION WITH MEL-26, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   PRO-99 AND GLU-308.
RX   PubMed=22621901; DOI=10.1091/mbc.e12-01-0055;
RA   Wilson K.J., Qadota H., Mains P.E., Benian G.M.;
RT   "UNC-89 (obscurin) binds to MEL-26, a BTB-domain protein, and affects the
RT   function of MEI-1 (katanin) in striated muscle of Caenorhabditis elegans.";
RL   Mol. Biol. Cell 23:2623-2634(2012).
RN   [13]
RP   FUNCTION, INTERACTION WITH MEL-26, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   PRO-235.
RX   PubMed=23918937; DOI=10.1083/jcb.201304174;
RA   Gomes J.E., Tavernier N., Richaudeau B., Formstecher E., Boulin T.,
RA   Mains P.E., Dumont J., Pintard L.;
RT   "Microtubule severing by the katanin complex is activated by PPFR-1-
RT   dependent MEI-1 dephosphorylation.";
RL   J. Cell Biol. 202:431-439(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) IN COMPLEX WITH ATP, FUNCTION,
RP   CATALYTIC ACTIVITY, SUBUNIT, AND MUTAGENESIS OF ASP-322; ARG-351; ARG-352
RP   AND PHE-469.
RX   PubMed=28783150; DOI=10.1038/nsmb.3448;
RA   Zehr E., Szyk A., Piszczek G., Szczesna E., Zuo X., Roll-Mecak A.;
RT   "Katanin spiral and ring structures shed light on power stroke for
RT   microtubule severing.";
RL   Nat. Struct. Mol. Biol. 24:717-725(2017).
CC   -!- FUNCTION: Catalytic subunit of a complex which severs microtubules in
CC       an ATP-dependent manner (PubMed:28783150). Microtubule severing may
CC       promote rapid reorganization of cellular microtubule arrays. Required
CC       specifically for meiotic spindle formation in the female germline; the
CC       presence of this protein is inimical to the formation of mitotic
CC       spindles (PubMed:8027178, PubMed:10809666, PubMed:12885567,
CC       PubMed:19087961, PubMed:23918937). In body wall muscles, regulates
CC       organization of myosin thick filaments (PubMed:22621901).
CC       {ECO:0000255|HAMAP-Rule:MF_03023, ECO:0000269|PubMed:10809666,
CC       ECO:0000269|PubMed:12885567, ECO:0000269|PubMed:19087961,
CC       ECO:0000269|PubMed:22621901, ECO:0000269|PubMed:28783150,
CC       ECO:0000269|PubMed:8027178}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=n ATP + n H2O + a microtubule = n ADP + n phosphate + (n+1)
CC         alpha/beta tubulin heterodimers.; EC=5.6.1.1;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03023,
CC         ECO:0000269|PubMed:28783150};
CC   -!- ACTIVITY REGULATION: ATPase activity is stimulated by microtubules,
CC       which promote homooligomerization. ATP-dependent microtubule severing
CC       is stimulated by interaction with mei-2. {ECO:0000255|HAMAP-
CC       Rule:MF_03023}.
CC   -!- SUBUNIT: Homohexamer; ATP hydrolysis initiates a cycle between an open
CC       spiral and a closed ring conformation which is probably involved in
CC       pulling tubulin dimers out from microtubules (PubMed:28783150).
CC       Interacts with mei-2, which may serve as a targeting subunit
CC       (PubMed:10809666). Interacts with mel-26, which targets mei-1 for
CC       ubiquitin mediated proteolysis (PubMed:13679921, PubMed:14528312,
CC       PubMed:23918937). Interacts with phosphatase pph-4.1 (PubMed:19087961).
CC       {ECO:0000255|HAMAP-Rule:MF_03023, ECO:0000269|PubMed:10809666,
CC       ECO:0000269|PubMed:13679921, ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:19087961, ECO:0000269|PubMed:22621901,
CC       ECO:0000269|PubMed:23918937, ECO:0000269|PubMed:28783150}.
CC   -!- INTERACTION:
CC       P34808; Q9XTS1: CELE_F47G4.4; NbExp=3; IntAct=EBI-323248, EBI-312192;
CC       P34808; Q9XTS3: CELE_F47G4.5; NbExp=4; IntAct=EBI-323248, EBI-2417913;
CC       P34808; Q9XTF3-2: mbk-2; NbExp=2; IntAct=EBI-323248, EBI-2565597;
CC       P34808; P34808: mei-1; NbExp=6; IntAct=EBI-323248, EBI-323248;
CC       P34808; O44740: mei-2; NbExp=3; IntAct=EBI-323248, EBI-323243;
CC       P34808; Q94420: mel-26; NbExp=6; IntAct=EBI-323248, EBI-320790;
CC       P34808-2; Q94420: mel-26; NbExp=3; IntAct=EBI-521381, EBI-320790;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000255|HAMAP-Rule:MF_03023, ECO:0000269|PubMed:10809666,
CC       ECO:0000269|PubMed:12781129, ECO:0000269|PubMed:8027178}. Chromosome
CC       {ECO:0000269|PubMed:12781129, ECO:0000269|PubMed:16338136}. Cytoplasm
CC       {ECO:0000269|PubMed:16338136}. Note=Localizes to the spindle poles and
CC       condensed chromatin during female meiosis (PubMed:10809666,
CC       PubMed:12781129, PubMed:8027178, PubMed:16338136). This localization
CC       requires mei-2 (PubMed:10809666). Also localizes to the polar body
CC       (PubMed:12781129). Ser-92 phosphorylated mei-1 is first detected on the
CC       maternal chromatin in anaphase of meiosis I, then localizes to the
CC       cytoplasm during meiosis II and quickly disappears between pronuclear
CC       formation and the first cell division, except in the polar bodies
CC       (PubMed:16338136). {ECO:0000269|PubMed:10809666,
CC       ECO:0000269|PubMed:12781129, ECO:0000269|PubMed:16338136,
CC       ECO:0000269|PubMed:8027178}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P34808-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P34808-2; Sequence=VSP_012951;
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in the female germline.
CC       Degradation at the meiosis-mitosis transition reduces cytoplasmic
CC       microtubule severing activity, thereby allowing the formation of larger
CC       mitotic spindles. {ECO:0000269|PubMed:8027178}.
CC   -!- PTM: Phosphorylated (PubMed:16338136, PubMed:23918937). Phosphorylation
CC       by mbk-2 is required for its rapid degradation following meiosis II
CC       (PubMed:16338136). Likely dephosphorylated by the PP4 complex composed
CC       of catalytic subunit pph-4.1 and regulatory subunit ppfr-1
CC       (PubMed:23918937). {ECO:0000269|PubMed:16338136,
CC       ECO:0000269|PubMed:23918937}.
CC   -!- PTM: Polyubiquitination targets the protein for rapid degradation via
CC       the ubiquitin system at the end of meiosis. The BTB domain protein mel-
CC       26 may serve to specifically target mei-1 for ubiquitination by cul-3
CC       containing complexes. The cul-3 protein is in turn regulated by
CC       neddylation by ned-8.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown at the L1 larval stage
CC       results in the disorganization of myosin thick filaments in adult body
CC       wall muscles characterized by the formation of abnormal myosin heavy
CC       chain myo-3 aggregates and V-shaped crossing of A-bands. In addition,
CC       body wall muscle cells appear shorter and broader.
CC       {ECO:0000269|PubMed:22621901}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. Katanin p60 subunit A1
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03023}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L25423; AAA28109.1; -; Genomic_DNA.
DR   EMBL; Z75713; CAB00052.1; -; Genomic_DNA.
DR   EMBL; Z75713; CAD56596.1; -; Genomic_DNA.
DR   PIR; S47861; S47861.
DR   PIR; T24316; T24316.
DR   RefSeq; NP_492257.1; NM_059856.6. [P34808-1]
DR   RefSeq; NP_871793.1; NM_181993.5.
DR   PDB; 5WC0; EM; 4.40 A; A/B/C/D/E/F=1-472.
DR   PDB; 5WC1; X-ray; 3.30 A; A=1-472.
DR   PDB; 5WCB; EM; 6.00 A; A/B/C/D/E/F=1-472.
DR   PDB; 6B5D; X-ray; 3.10 A; A=164-471.
DR   PDB; 6UGD; EM; 3.50 A; A/B/C/D/E/F=1-472.
DR   PDB; 6UGE; EM; 3.60 A; A/B/C/D/E/F=1-472.
DR   PDB; 6UGF; EM; 4.20 A; A/B/C/D/E/F=1-472.
DR   PDBsum; 5WC0; -.
DR   PDBsum; 5WC1; -.
DR   PDBsum; 5WCB; -.
DR   PDBsum; 6B5D; -.
DR   PDBsum; 6UGD; -.
DR   PDBsum; 6UGE; -.
DR   PDBsum; 6UGF; -.
DR   AlphaFoldDB; P34808; -.
DR   SMR; P34808; -.
DR   BioGRID; 38046; 14.
DR   ComplexPortal; CPX-3889; Katanin complex.
DR   DIP; DIP-25343N; -.
DR   IntAct; P34808; 7.
DR   MINT; P34808; -.
DR   STRING; 6239.T01G9.5b; -.
DR   iPTMnet; P34808; -.
DR   EPD; P34808; -.
DR   PaxDb; P34808; -.
DR   PeptideAtlas; P34808; -.
DR   PRIDE; P34808; -.
DR   EnsemblMetazoa; T01G9.5a.1; T01G9.5a.1; WBGene00003183. [P34808-1]
DR   EnsemblMetazoa; T01G9.5b.1; T01G9.5b.1; WBGene00003183. [P34808-2]
DR   GeneID; 172612; -.
DR   UCSC; T01G9.5a.1; c. elegans. [P34808-1]
DR   CTD; 249838; -.
DR   WormBase; T01G9.5a; CE06342; WBGene00003183; mei-1. [P34808-1]
DR   WormBase; T01G9.5b; CE32479; WBGene00003183; mei-1. [P34808-2]
DR   eggNOG; KOG0738; Eukaryota.
DR   GeneTree; ENSGT00940000169739; -.
DR   HOGENOM; CLU_000688_21_1_1; -.
DR   InParanoid; P34808; -.
DR   OMA; EVCWEDI; -.
DR   OrthoDB; 714481at2759; -.
DR   PhylomeDB; P34808; -.
DR   BRENDA; 5.6.1.1; 1045.
DR   SignaLink; P34808; -.
DR   PRO; PR:P34808; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00003183; Expressed in embryo and 4 other tissues.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-UniRule.
DR   GO; GO:0000785; C:chromatin; IDA:WormBase.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008352; C:katanin complex; IDA:UniProtKB.
DR   GO; GO:0072687; C:meiotic spindle; IDA:WormBase.
DR   GO; GO:0090619; C:meiotic spindle pole; IDA:WormBase.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0005819; C:spindle; IDA:WormBase.
DR   GO; GO:0000922; C:spindle pole; IDA:ComplexPortal.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0090736; F:MATH domain binding; IPI:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008568; F:microtubule severing ATPase activity; IDA:WormBase.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:UniProtKB.
DR   GO; GO:0007143; P:female meiotic nuclear division; IMP:WormBase.
DR   GO; GO:0051229; P:meiotic spindle disassembly; IMP:WormBase.
DR   GO; GO:0000212; P:meiotic spindle organization; IMP:WormBase.
DR   GO; GO:0007019; P:microtubule depolymerization; IDA:WormBase.
DR   GO; GO:0051013; P:microtubule severing; IMP:UniProtKB.
DR   GO; GO:1902120; P:negative regulation of meiotic spindle elongation; IMP:WormBase.
DR   GO; GO:0071688; P:striated muscle myosin thick filament assembly; IMP:UniProtKB.
DR   DisProt; DP02999; -.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_03023; Katanin_p60_A1; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR028596; KATNA1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF17862; AAA_lid_3; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00674; AAA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Chromosome; Cytoplasm; Cytoskeleton; Isomerase; Meiosis; Microtubule;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..472
FT                   /note="Meiotic spindle formation protein mei-1"
FT                   /id="PRO_0000084599"
FT   REGION          83..161
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        131..161
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         233..240
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03023,
FT                   ECO:0000269|PubMed:28783150, ECO:0007744|PDB:5WC0,
FT                   ECO:0007744|PDB:5WCB"
FT   BINDING         351..352
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:28783150,
FT                   ECO:0007744|PDB:5WC0, ECO:0007744|PDB:5WCB"
FT   MOD_RES         92
FT                   /note="Phosphoserine; by mbk-2"
FT                   /evidence="ECO:0000269|PubMed:16338136"
FT   VAR_SEQ         416
FT                   /note="Y -> YFRY (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_012951"
FT   MUTAGEN         36
FT                   /note="R->C: In ct46ct99; loss of function. Does not affect
FT                   mei-1 degradation. Prevents mei-1 degradation during the
FT                   transition from meiosis to mitosis; when associated with A-
FT                   92."
FT                   /evidence="ECO:0000269|PubMed:16338136,
FT                   ECO:0000269|PubMed:8150281"
FT   MUTAGEN         66
FT                   /note="E->K: In ct46sb18; gain of function."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         92
FT                   /note="S->A: Abolishes phosphorylation by mbk-2. Abolishes
FT                   interaction with mel-26. Prevents mei-1 degradation during
FT                   the transition from meiosis to mitosis; when associated
FT                   with C-36."
FT                   /evidence="ECO:0000269|PubMed:16338136,
FT                   ECO:0000269|PubMed:23918937"
FT   MUTAGEN         92
FT                   /note="S->D: Phosphomimetic mutant. No effect on the
FT                   interaction with mel-26."
FT                   /evidence="ECO:0000269|PubMed:23918937"
FT   MUTAGEN         99
FT                   /note="P->L: In ct46; gain of function. Embryonic lethal.
FT                   Abolishes interaction with mel-26 and probably mel-26-
FT                   mediated degradation. Simultaneous RNAi-mediated knockdown
FT                   of ppfr-1, pph-4.1 or ppfr-4, partially rescues embryonic
FT                   lethality. Myosin thick filaments are disorganized in body
FT                   wall muscles in an unc-29 (e1072) mutant background."
FT                   /evidence="ECO:0000269|PubMed:19087961,
FT                   ECO:0000269|PubMed:22621901, ECO:0000269|PubMed:8150281"
FT   MUTAGEN         126
FT                   /note="G->S: In ct46sb9 and ct46sb17; gain of function."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         128
FT                   /note="R->C: In ct46sb22; gain of function."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         195
FT                   /note="I->K: In ct46sb3; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         225
FT                   /note="P->L: In b284; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         231
FT                   /note="L->P: In ct81; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         235
FT                   /note="P->L: In ct93; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         235
FT                   /note="P->S: In ct46ct103; dominant negative. Formation of
FT                   an abnormally large polar body during oocyte meiosis II.
FT                   Increased in metaphase and anaphase meiotic spindle length,
FT                   failure of chromosomes to align on the metaphase plate
FT                   persistence of spindle poles during anaphase resulting in
FT                   their mis-positioning and delay in anaphase meiotic spindle
FT                   disassembly."
FT                   /evidence="ECO:0000269|PubMed:23918937,
FT                   ECO:0000269|PubMed:8150281"
FT   MUTAGEN         308
FT                   /note="E->D: In ct46ct101; null. Formation of an abnormally
FT                   large polar body during oocyte meiosis II. Myosin thick
FT                   filaments are disorganized in body wall muscles in an unc-
FT                   29 (e1072) mutant background."
FT                   /evidence="ECO:0000269|PubMed:19087961,
FT                   ECO:0000269|PubMed:22621901, ECO:0000269|PubMed:8150281"
FT   MUTAGEN         322
FT                   /note="D->R: Severe loss of ATPase activity and complete
FT                   loss of microtubule severing activity."
FT                   /evidence="ECO:0000269|PubMed:28783150"
FT   MUTAGEN         351
FT                   /note="R->A: Severe loss of ATPase activity and complete
FT                   loss of microtubule severing activity."
FT                   /evidence="ECO:0000269|PubMed:28783150"
FT   MUTAGEN         352
FT                   /note="R->A: Severe loss of ATPase activity and complete
FT                   loss of microtubule severing activity."
FT                   /evidence="ECO:0000269|PubMed:28783150"
FT   MUTAGEN         360
FT                   /note="P->S: In ct46sb23; gain of function."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         414
FT                   /note="R->K: In ct46ct89; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   MUTAGEN         469
FT                   /note="F->A: Severe loss of ATPase activity and complete
FT                   loss of microtubule severing activity."
FT                   /evidence="ECO:0000269|PubMed:28783150"
FT   MUTAGEN         470
FT                   /note="G->D: In ct46ct82; dominant negative."
FT                   /evidence="ECO:0000269|PubMed:8150281"
FT   HELIX           175..181
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   TURN            185..187
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           199..208
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           210..214
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   TURN            216..218
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           221..223
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          227..232
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           239..249
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          250..252
FT                   /evidence="ECO:0007829|PDB:6UGD"
FT   STRAND          253..258
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           259..264
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           271..283
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          284..292
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           294..296
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           311..314
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           316..324
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          333..340
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           347..352
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          355..358
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           364..374
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   TURN            375..377
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           386..392
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:5WC1"
FT   HELIX           398..414
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           419..421
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   STRAND          423..425
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           428..435
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           440..449
FT                   /evidence="ECO:0007829|PDB:6B5D"
FT   HELIX           456..465
FT                   /evidence="ECO:0007829|PDB:6B5D"
SQ   SEQUENCE   472 AA;  51739 MW;  167A3929E573CD59 CRC64;
     MNGDVQSVIR GYLERAQVAK TMSDAGRWNE AGDLLRQLMT DVKSCKISAS NRDEHDARNT
     FLRALEANLK LVQQNVRDED DLHEAMTRQS GSPEPPADPD VWSKPSPPLP SSSKFGATKK
     GVGAAGPRPR EISKSTSSMS TNPADVKPAN PTQGILPQNS AGDSFDASAY DAYIVQAVRG
     TMATNTENTM SLDDIIGMHD VKQVLHEAVT LPLLVPEFFQ GLRSPWKAMV LAGPPGTGKT
     LIARAIASES SSTFFTVSST DLSSKWRGDS EKIVRLLFEL ARFYAPSIIF IDEIDTLGGQ
     RGNSGEHEAS RRVKSEFLVQ MDGSQNKFDS RRVFVLAATN IPWELDEALR RRFEKRIFIP
     LPDIDARKKL IEKSMEGTPK SDEINYDDLA ARTEGFSGAD VVSLCRTAAI NVLRRYDTKS
     LRGGELTAAM ESLKAELVRN IDFEAALQAV SPSAGPDTML KCKEWCDSFG AM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024